Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer

被引：0
|
作者：
Wen Ouyang
Jing Yu
Yan Zhou
Jing Hu
Zhao huang
Junhong Zhang
Conghua Xie
机构：
[1] Zhongnan Hospital of Wuhan University,Department of Radiation and Medical Oncology
[2] Zhongnan Hospital of Wuhan University,Hubei Key Laboratory of Tumor Biological Behaviors
[3] Zhongnan Hospital of Wuhan University,Hubei Clinical Cancer Study Center
来源：
BMC Cancer | / 20卷
关键词：
Non-small cell lung cancer; Epidermal growth factor receptor; Brain metastases; Risk factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer
    Ouyang, Wen
    Yu, Jing
    Zhou, Yan
    Hu, Jing
    Huang, Zhao
    Zhang, Junhong
    Xie, Conghua
    BMC CANCER, 2020, 20 (01)
  • [2] Factors Associated With Distant Metastasis in EGFR-mutated Non-small Cell Lung Cancer Patients: Logistic Analysis
    Watanabe, Hiroko
    Okauchi, Shinichiro
    Miyazaki, Kunihiko
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    IN VIVO, 2019, 33 (04): : 1369 - 1372
  • [3] Efficacy of brain radiotherapy plus EGFR-TKI for EGFR-mutated non-small cell lung cancer patients who develop brain metastasis
    Wang, Wenxian
    Song, Zhengbo
    Zhang, Yiping
    ARCHIVES OF MEDICAL SCIENCE, 2018, 14 (06) : 1298 - 1307
  • [4] The Management of Brain Metastases in Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer
    O'Rourke, Noelle
    Gray, Christine M. N.
    Coyte, Aishah
    Featherstone, Carolyn
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S526 - S526
  • [5] Modulation of Fexofenadine Pharmacokinetics by Osimertinib in Patients With Advanced EGFR-Mutated Non-Small Cell Lung Cancer
    Calvo, Emiliano
    Lee, Jong-Seok
    Kim, Sang-We
    Moreno, Victor
    deCastro Carpeno, Javier
    Weilert, Doris
    Laus, Gianluca
    Mann, Helen
    Vishwanathan, Karthick
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (08): : 1099 - 1109
  • [6] Risk Factors of Brain Metastasis during the Course of EGFR-TKIs Therapy for Patients with EGFR-Mutated Advanced Lung Adenocarcinoma
    Zhu, Hui
    Ma, Xiaoyan
    Yu, Jinming
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1484 - S1484
  • [7] Combined action of EGFR tyrosine kinase inhibitors and whole-brain radiotherapy on EGFR-mutated non-small-cell lung cancer patients with brain metastasis
    Lu, Yunyun
    Fan, Yun
    ONCOTARGETS AND THERAPY, 2016, 9 : 1135 - 1143
  • [8] Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs
    Gui, Qi
    Liu, Jiangang
    Li, Dapeng
    Xu, Chengcheng
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [9] Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs
    Qi Gui
    Jiangang Liu
    Dapeng Li
    Chengcheng Xu
    World Journal of Surgical Oncology, 15
  • [10] A Single-Institution Experience of Afatinib in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer
    Minemura, Hiroyuki
    Yokouchi, Hiroshi
    Hirai, Kenichiro
    Koizumi, Tatsuhiko
    Kanazawa, Kenya
    Tanino, Yoshinori
    Munakata, Mitsuru
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1230 - S1231
12345